| 000 | 01401 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513190454.0 | ||
| 264 | 0 | _c19990830 | |
| 008 | 199908s 0 0 eng d | ||
| 022 | _a1073-449X | ||
| 024 | 7 |
_a10.1164/ajrccm.160.2.9901049 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSnyder, D C | |
| 245 | 0 | 0 |
_aCost-effectiveness analysis of directly observed therapy for patients with tuberculosis at low risk for treatment default. _h[electronic resource] |
| 260 |
_bAmerican journal of respiratory and critical care medicine _cAug 1999 |
||
| 300 |
_a582-6 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntitubercular Agents _xeconomics |
| 650 | 0 | 4 | _aCalifornia |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHealth Resources _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOutcome and Process Assessment, Health Care |
| 650 | 0 | 4 | _aPatient Compliance |
| 650 | 0 | 4 | _aPatient Dropouts |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 |
_aSelf Administration _xeconomics |
| 650 | 0 | 4 |
_aTuberculosis, Pulmonary _xdrug therapy |
| 700 | 1 | _aChin, D P | |
| 773 | 0 |
_tAmerican journal of respiratory and critical care medicine _gvol. 160 _gno. 2 _gp. 582-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1164/ajrccm.160.2.9901049 _zAvailable from publisher's website |
| 999 |
_c10388520 _d10388520 |
||